Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Seif Al Abri, Ministry of Health Oman
  • ,
  • Akiko Kowada, Ota City Office
  • ,
  • Fatma Yaqoubi, Ministry of Health Oman
  • ,
  • Sulien Al Khalili, Ministry of Health Oman
  • ,
  • Nduku Ndunda, Qiagen
  • ,
  • Eskild Petersen

Objective: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman. Methods: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment. Results: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved. Conclusions: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.

OriginalsprogEngelsk
TidsskriftInternational Journal of Infectious Diseases
Vol/bind92
Sider (fra-til)S72-S77
Antal sider6
ISSN1201-9712
DOI
StatusUdgivet - 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 183161064